BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,120,000 | -97.7% | 26,324 | -97.7% | 0.01% | -98.5% |
Q3 2020 | $92,847,000 | +13.1% | 1,154,558 | +21.1% | 0.60% | +9.8% |
Q2 2020 | $82,067,000 | +435.5% | 953,162 | +404.9% | 0.54% | +367.2% |
Q1 2020 | $15,326,000 | +200.1% | 188,780 | +223.3% | 0.12% | +300.0% |
Q3 2019 | $5,107,000 | +516.0% | 58,389 | +477.1% | 0.03% | +480.0% |
Q2 2019 | $829,000 | -80.5% | 10,117 | -80.6% | 0.01% | -66.7% |
Q1 2019 | $4,246,000 | -87.1% | 52,230 | -89.6% | 0.02% | -95.3% |
Q4 2018 | $32,912,000 | -35.4% | 500,028 | -24.4% | 0.32% | +82.3% |
Q3 2018 | $50,986,000 | +70.3% | 661,368 | +63.1% | 0.18% | +3.6% |
Q2 2018 | $29,940,000 | -27.1% | 405,482 | -35.8% | 0.17% | -18.0% |
Q1 2018 | $41,079,000 | +1549.8% | 631,610 | +1539.5% | 0.21% | +1371.4% |
Q4 2017 | $2,490,000 | +29.7% | 38,525 | +26.4% | 0.01% | +16.7% |
Q3 2017 | $1,920,000 | +8.2% | 30,473 | +4.7% | 0.01% | -7.7% |
Q2 2017 | $1,775,000 | -97.3% | 29,097 | -97.7% | 0.01% | -97.5% |
Q1 2017 | $65,780,000 | +340.4% | 1,264,993 | +456.3% | 0.52% | +13.6% |
Q3 2013 | $14,937,000 | +127.2% | 227,381 | +139.6% | 0.46% | -11.9% |
Q2 2013 | $6,573,000 | – | 94,883 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |